Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
43 studies found for:    "Thyroid cancer anaplastic"
Show Display Options
RSS Create an RSS feed from your search for:
"Thyroid cancer anaplastic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Intervention: Drug: Lenvatinib
2 Completed Review of Multimodality Management of Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Intervention:
3 Withdrawn Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Interventions: Drug: Fosbretabulin + paclitaxel + carboplatin;   Drug: Placebo + paclitaxel + carboplatin
4 Recruiting interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT)
Condition: Anaplastic Thyroid Cancer
Intervention: Other: Tissue, blood and clinical data collection
5 Recruiting Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Intervention: Drug: Pembrolizumab
6 Withdrawn A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers
Condition: Anaplastic Thyroid Cancers
Intervention: Drug: Adalimumab
7 Terminated
Has Results
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Interventions: Drug: CA4P;   Drug: paclitaxel;   Drug: carboplatin
8 Recruiting A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Thyroid Cancer
Intervention: Drug: MLN0128
9 Active, not recruiting
Has Results
A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
Conditions: Solid Tumor;   Anaplastic Thyroid Cancer
Interventions: Drug: Crolibulin;   Drug: Cisplatin
10 Terminated
Has Results
Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Recurrent Thyroid Cancer
Intervention: Drug: sorafenib tosylate
11 Recruiting Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer;   Recurrent Thyroid Cancer
Interventions: Drug: efatutazone;   Drug: paclitaxel
12 Completed A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPARγ Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy
Condition: Anaplastic Thyroid Cancer
Interventions: Drug: CS7017;   Drug: Paclitaxel
13 Recruiting Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer
Conditions: Metastatic Anaplastic Thyroid Cancer;   Locally Advanced Anaplastic, Undifferentiated Thyroid Cancer
Intervention: Drug: Ceritinib
14 Terminated
Has Results
Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma
Condition: Thyroid Cancer
Intervention: Drug: Imatinib
15 Terminated Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer
Condition: Head and Neck Cancer
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: fosbretabulin disodium;   Radiation: radiation therapy
16 Completed Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer
Condition: Head and Neck Cancer
Intervention: Drug: fosbretabulin disodium
17 Unknown  Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer
Conditions: Thyroid Neoplasms;   Carcinoma;   Thyroid Cancer;   Metastatic Cancer
Intervention: Drug: Bevacizumab
18 Not yet recruiting Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients
Condition: Thyroid Cancer
Intervention:
19 Recruiting A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)
Condition: Thyroid Cancer, Anaplastic
Intervention: Drug: Lenvatinib 24 mg
20 Recruiting Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer
Condition: Thyroid Gland Undifferentiated (Anaplastic) Carcinoma
Interventions: Radiation: Intensity-Modulated Radiation Therapy;   Drug: Paclitaxel;   Drug: Pazopanib Hydrochloride;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.